Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley P Ghiaseddin

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Treatment Options in Oncology|August 1, 2020
Tumor Treating Fields in the Management of Patients with Malignant GliomasAshley P Ghiaseddin, David Shin, Kaitlyn Melnick, et al.
Journal of Neuro-Oncology|August 7, 2020
In situ vaccination with laser interstitial thermal therapy augments immunotherapy in malignant gliomasDavid H Shin, Kaitlyn F Melnick, David D Tran, et al.
Human Vaccines & Immunotherapeutics|August 19, 2025
Systemic mRNA aggregates elicit immunologic reprogramming that unlocks anti-cancer immunityHector R Mendez-Gomez, John A Ligon, Ashley P Ghiaseddin, et al.
JCO Precision Oncology|February 17, 2022
Eleven Month Progression-Free Survival on Vemurafenib Monotherapy in a Patient With Recurrent and Metastatic <i>BRAF</i> V600E-Mutated Glioblastoma WHO Grade 4Kanita Beba Abadal, Meggen A Walsh, Anthony T Yachnis, et al.
Med (New York, N.Y.)|June 4, 2025
Efficacy and safety of adjuvant TTFields plus pembrolizumab and temozolomide in newly diagnosed glioblastoma: A phase 2 studyDongjiang Chen, Son B Le, Ashley P Ghiaseddin, et al.
Neuro-Oncology Practice|January 8, 2025
How do I prescribe and manage mIDH inhibitors in patients with IDH-mutant glioma?Megan E H Still, Rachel S F Moor, Ashley P Ghiaseddin, et al.
World Neurosurgery|September 22, 2023
The Safety and Efficacy of Concurrent Immune Checkpoint Blockade and Stereotactic Radiosurgery Therapy with Practitioner and Researcher RecommendationsYusuf Mehkri, Sonora Andromeda Windermere, Megan E H Still, et al.
Neuro-Oncology Advances|March 15, 2024
Advancements in chimeric antigen receptor-expressing T-cell therapy for glioblastoma multiforme: Literature review and future directionsMichael Goutnik, Alexandria Iakovidis, Megan E H Still, et al.
Cancers|June 26, 2026
Emerging Perspectives on Adverse Childhood Experiences and Brain Cancer ImmunotherapyJohn W Figg, Julian Mark, Caretia J Washington, et al.
Surgical Neurology International|July 5, 2021
Inflammatory myofibroblastic tumor masquerading as an anterior choroidal artery fusiform aneurysmSamuel Louis Malnik, Rachel Freedman Moor, David Shin, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Treatment Options in Oncology|August 1, 2020
Tumor Treating Fields in the Management of Patients with Malignant GliomasAshley P Ghiaseddin, David Shin, Kaitlyn Melnick, et al.
Journal of Neuro-Oncology|August 7, 2020
In situ vaccination with laser interstitial thermal therapy augments immunotherapy in malignant gliomasDavid H Shin, Kaitlyn F Melnick, David D Tran, et al.
Human Vaccines & Immunotherapeutics|August 19, 2025
Systemic mRNA aggregates elicit immunologic reprogramming that unlocks anti-cancer immunityHector R Mendez-Gomez, John A Ligon, Ashley P Ghiaseddin, et al.
JCO Precision Oncology|February 17, 2022
Eleven Month Progression-Free Survival on Vemurafenib Monotherapy in a Patient With Recurrent and Metastatic <i>BRAF</i> V600E-Mutated Glioblastoma WHO Grade 4Kanita Beba Abadal, Meggen A Walsh, Anthony T Yachnis, et al.
Med (New York, N.Y.)|June 4, 2025
Efficacy and safety of adjuvant TTFields plus pembrolizumab and temozolomide in newly diagnosed glioblastoma: A phase 2 studyDongjiang Chen, Son B Le, Ashley P Ghiaseddin, et al.
Neuro-Oncology Practice|January 8, 2025
How do I prescribe and manage mIDH inhibitors in patients with IDH-mutant glioma?Megan E H Still, Rachel S F Moor, Ashley P Ghiaseddin, et al.
World Neurosurgery|September 22, 2023
The Safety and Efficacy of Concurrent Immune Checkpoint Blockade and Stereotactic Radiosurgery Therapy with Practitioner and Researcher RecommendationsYusuf Mehkri, Sonora Andromeda Windermere, Megan E H Still, et al.
Neuro-Oncology Advances|March 15, 2024
Advancements in chimeric antigen receptor-expressing T-cell therapy for glioblastoma multiforme: Literature review and future directionsMichael Goutnik, Alexandria Iakovidis, Megan E H Still, et al.
Cancers|June 26, 2026
Emerging Perspectives on Adverse Childhood Experiences and Brain Cancer ImmunotherapyJohn W Figg, Julian Mark, Caretia J Washington, et al.
Surgical Neurology International|July 5, 2021
Inflammatory myofibroblastic tumor masquerading as an anterior choroidal artery fusiform aneurysmSamuel Louis Malnik, Rachel Freedman Moor, David Shin, et al.
Pageof 2